Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development

被引:0
|
作者
Yanying Huo
Pier Selenica
Amar H. Mahdi
Fresia Pareja
Kelly Kyker-Snowman
Ying Chen
Rahul Kumar
Arnaud Da Cruz Paula
Thais Basili
David N. Brown
Xin Pei
Nadeem Riaz
Yongmei Tan
Yu-Xiu Huang
Tao Li
Nicola J. Barnard
Jorge S. Reis-Filho
Britta Weigelt
Bing Xia
机构
[1] Rutgers Cancer Institute of New Jersey,Department of Radiation Oncology
[2] Rutgers Robert Wood Johnson Medical School,Department of Pathology
[3] Memorial Sloan Kettering Cancer Center,Department of Radiation Oncology
[4] Memorial Sloan Kettering Cancer Center,Department of Pathology and Laboratory Medicine
[5] Stomatological Hospital of Guangzhou Medical University,Department of Physiology, College of Medicine
[6] The First Affiliated Hospital of Fujian Medical University,Centre for Brain Research
[7] Rutgers Robert Wood Johnson Medical School,undefined
[8] Al-Mustansiriyah University,undefined
[9] Indian Institute of Science (IISc),undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Inherited mutations in BRCA1, BRCA2, and PALB2 cause a high risk of breast cancer. Here, we conducted parallel conditional knockout (CKO) of Brca1, Palb2, and Brca2, individually and in combination, along with one copy of Trp53, in the mammary gland of nulliparous female mice. We observed a functional equivalence of the three genes in their basic tumor-suppressive activity, a linear epistasis of Palb2 and Brca2, but complementary roles of Brca1 and Palb2 in mammary tumor suppression, as combined ablation of either Palb2 or Brca2 with Brca1 led to delayed tumor formation. Whole-exome sequencing (WES) revealed both similarities and differences between Brca1 and Palb2 or Brca2 null tumors. Analyses of mouse mammary glands and cultured human cells showed that combined loss of BRCA1 and PALB2 led to high levels of reactive oxygen species (ROS) and increased apoptosis, implicating oxidative stress in the delayed tumor development in Brca1;Palb2 double CKO mice. The functional complementarity between BRCA1 and PALB2/BRCA2 and the role of ROS in tumorigenesis require further investigation.
引用
收藏
相关论文
共 50 条
  • [31] Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland
    P. Wojcik
    M. Jasiowka
    E. Strycharz
    M. Sobol
    D. Hodorowicz-Zaniewska
    P. Skotnicki
    T. Byrski
    P. Blecharz
    E. Marczyk
    I. Cedrych
    J. Jakubowicz
    J. Lubiński
    V. Sopik
    S. Narod
    P. Pierzchalski
    Hereditary Cancer in Clinical Practice, 14
  • [32] Frequency of large rearrangements in BRCA1, BRCA2, ATM, CHEK2, and PALB2 in hereditary cancer testing
    Bissonnette, J.
    Doonanco, K.
    Xu, Z.
    Klein, R. T.
    Hruska, K. S.
    CANCER RESEARCH, 2016, 76
  • [33] Genetic variations of BRCA1 and BRCA2 genes in dogs with mammary tumours
    S. O. Enginler
    I. Akış
    T. S. F. Toydemir
    K. Oztabak
    D. Haktanir
    M. C. Gündüz
    I. Kırşan
    I. Fırat
    Veterinary Research Communications, 2014, 38 : 21 - 27
  • [34] Genetic variations of BRCA1 and BRCA2 genes in dogs with mammary tumours
    Enginler, S. O.
    Akis, I.
    Toydemir, T. S. F.
    Oztabak, K.
    Haktanir, D.
    Gunduz, M. C.
    Kirsan, I.
    Firat, I.
    VETERINARY RESEARCH COMMUNICATIONS, 2014, 38 (01) : 21 - 27
  • [35] Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer
    Bowman-Colin, Christian
    Xia, Bing
    Bunting, Samuel
    Klijn, Christiaan
    Drost, Rinske
    Bouwman, Peter
    Fineman, Laura
    Chen, Xixi
    Culhane, Aedin C.
    Cai, Hong
    Rodig, Scott J.
    Bronson, Roderick T.
    Jonkers, Jos
    Nussenzweig, Andre
    Kanellopoulou, Chryssa
    Livingston, David M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (21) : 8632 - 8637
  • [36] Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma
    Shoko Takeuchi
    Manami Doi
    Naoki Ikari
    Masakazu Yamamoto
    Toru Furukawa
    Scientific Reports, 8
  • [37] Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
    Yadav, Siddhartha
    Boddicker, Nicholas J.
    Na, Jie
    Polley, Eric C.
    Hu, Chunling
    Hart, Steven N.
    Gnanaolivu, Rohan D.
    Larson, Nicole
    Holtegaard, Susan
    Huang, Huaizhi
    Dunn, Carolyn A.
    Teras, Lauren R.
    Patel, Alpa V.
    Lacey, James V.
    Neuhausen, Susan L.
    Martinez, Elena
    Haiman, Christopher
    Chen, Fei
    Ruddy, Kathryn J.
    Olson, Janet E.
    John, Esther M.
    Kurian, Allison W.
    Sandler, Dale P.
    O'Brien, Katie M.
    Taylor, Jack A.
    Weinberg, Clarice R.
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Zirpoli, Gary
    Goldgar, David E.
    Palmer, Julie R.
    Domchek, Susan M.
    Weitzel, Jeffrey N.
    Nathanson, Katherine L.
    Kraft, Peter
    Couch, Fergus J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (09) : 1703 - +
  • [38] BRCA1 and BRCA2
    Bertwistle, D
    Ashworth, A
    CURRENT BIOLOGY, 2000, 10 (16) : R582 - R582
  • [39] Characterising cancer risks for carriers of mutations in BRCA1, BRCA2, PALB2, and RAD51C genes
    Antoniou, Antonis C.
    CANCER RESEARCH, 2015, 75
  • [40] Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls
    Supriya Behl
    Nancy Hamel
    Manon de Ladurantaye
    Stéphanie Lepage
    Réjean Lapointe
    Anne-Marie Mes-Masson
    William D. Foulkes
    Scientific Reports, 10